![]() |
||
![]() |
English | Français |
|
|
![]() |
|||||||||||||||||||||||||||||||||||||
Who We Are One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since its founding in 1981, the company has introduced breakthrough treatments across several areas of medicine that have provided new hope for patients. Today, approximately 10,000 Genzyme employees serve patients in nearly 100 countries. Genzyme's products are focused on rare genetic diseases, multiple sclerosis, cardiovascular disease, and endocrinology. The company's commitment to innovation continues today with a substantial development program focused on these fields, as well as other areas of unmet medical need. Genzyme is a Sanofi company. Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets, and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
|
|
|||||||||||||||||||||||||||||||||||||
|
Privacy Policy - Canada USA | Terms and Conditions of Use | | © 2003-2012 Genzyme, a Sanofi company. All rights reserved. |